Results 241 to 250 of about 13,385,789 (308)

The <i>in vitro</i> replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication. [PDF]

J Virol
McCoullough LC, Sadauskas T, Sozzi V, Mak KY, Mason H, Littlejohn M, Revill PA.   +6 more
europepmc   +1 more source

Antiviral Therapy and Post‐Resection Outcomes in Patients With Hepatitis B Virus‐Related Hepatocellular Carcinoma

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 8, Page 1123-1134, October 2026.
In 902 patients with HBV‐related HCC undergoing curative resection, antiviral regimens (ETV, TDF, TAF) showed comparable recurrence‐free survival. However, TDF was independently associated with improved overall survival compared with ETV. ABSTRACT Background & Aims The comparative outcomes of entecavir (ETV), tenofovir disoproxil fumarate (TDF), and ...
Jaehong Jeong, Jung Pyo Hong, Dong Yun Kim, Jae Seung Lee, Mi Na Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hye Won Lee   +10 more
wiley   +1 more source

Awareness of Hepatitis B Virus (HBV) Screening Before Marriage and Pregnancy Among Adults in the Al-Baha Region, Saudi Arabia. [PDF]

Cureus
Agwa RH, Elwan TH, Alghamdi HAS, Alghamdi AAS, Altaweel FIA, Alghamdi AA, Alhussain HA, Alsawlihah KMA, Alzahrani FA.   +8 more
europepmc   +1 more source

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol

BJU International, Volume 138, Issue 4, Page 607-619, October 2026.
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan, Ethan Senior, Jessica Kendall, Jamie B. Oughton, Fiona Collinson, Jon Griffin, Rachel Hubbard, Steven Kennish, Aidan Noon, Derek J. Rosario, Irbaz B. Riaz, Julie Telliez, James W. F. Catto, Syed A. Hussain   +13 more
wiley   +1 more source

Hepatitis B virus (HBV) screening, linkage and retention-in-care in inclusion health populations: Evaluation of an outreach screening programme in London. [PDF]

J Infect
Martyn E, O'Regan S, Harris P, Leonard M, Veitch M, Sultan B, Matthews PC, Ghosh I, Story A, Surey J.   +9 more
europepmc   +1 more source

Real-Life Diagnostic Accuracy and Clinical Utility of Hepatitis B Virus (HBV) Nucleic Acid Testing Using the GeneXpert Point-of-Care Test System from Fresh Plasma and Dry Blood Spot Samples in The Gambia. [PDF]

Microorganisms
Ceesay A, Drammeh S, Ndow G, Jallow AOA, Nyang H, Bittaye B, Mendy FS, Secka O, D'Alessandro U, Shimakawa Y, Vo-Quang E, Testoni B, Thursz M, Lemoine M, Chemin I.   +14 more
europepmc   +1 more source

Assessing Physicians' Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City. [PDF]

J Community Health
Begum TF, Patil VS, Zhu L, Yeh MC, González E, Fraser MA, Lu W, Zhu S, Rubio-Torio N, Ma GX, Tan Y.   +10 more
europepmc   +1 more source

[Hepatitis B virus (HBV) (author's transl)].

Uirusu, 1979
H, Ohori, N, Ishida
openaire   +1 more source

Whole genome sequencing of hepatitis B virus (HBV) using tiled amplicon (HEP-TILE) and probe-based enrichment on Illumina and Nanopore platforms

Lumley SF, Kent C, Jennings D, Chai H, Airey G, Waddilove E, Delphin M, Trebes A, McNaughton AL, Mohammed KS, Wilkinson S, Wu Y, MacIntyre-Cockett G, Kimono B, Kwizera M, Ojambo K, Maponga TG, de Lara C, Martin J, Campbell J, Van Schalkwyk M, Goedhals D, Newton R, Barnes E, Loman NJ, Piazza P, Quick J, Ansari MA, Matthews PC.   +28 more
europepmc   +1 more source